<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01926951</url>
  </required_header>
  <id_info>
    <org_study_id>KM13-001</org_study_id>
    <nct_id>NCT01926951</nct_id>
  </id_info>
  <brief_title>Renal Denervation Using Externally Focused Therapeutic Ultrasound</brief_title>
  <official_title>A Feasibility Study: An Evaluation of Renal Denervation Using Externally Focused Therapeutic Ultrasound With External Targeting and Tracking on Patients With Refractory Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kona Medical Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kona Medical Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the effects of renal denervation using externally focused&#xD;
      therapeutic ultrasound with external targeting and tracking on patients with refractory&#xD;
      hypertension.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a prospective, multi-center trial wherein each included subject will receive&#xD;
      the experimental externally focused ultrasound renal denervation therapy. It will be&#xD;
      conducted on a maximum of twenty patients who meet the eligibility criteria and have signed&#xD;
      the informed consent form.&#xD;
&#xD;
      Safety is the primary endpoint of this study. Safety will be assessed by incidence and&#xD;
      evaluation of any serious adverse effects associated with the investigational procedure&#xD;
      through the 52-week evaluation. Clinical utility is a secondary endpoint of this study.&#xD;
      Clinical utility will be evaluated by comparing pre and post therapy systolic and diastolic&#xD;
      blood pressure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>52-week post-treatment</time_frame>
    <description>Safety will be assessed by incidence and evaluation of any serious adverse effects associated with the investigational procedure through 52-week evaluation. Included in this assessment will be the proportion of subjects with any of the following outcomes: 1) death, or 2) medical morbidity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Utility</measure>
    <time_frame>52-week post-treatment</time_frame>
    <description>Clinical utility will be evaluated by comparing pre and post therapy systolic and diastolic blood pressure.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Renal Denervation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Renal Denervation using the Kona Surround Sound Externally Focused Therapeutic Ultrasound therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Surround Sound Externally Focused Therapeutic Ultrasound</intervention_name>
    <description>Externally Focused Therapeutic Ultrasound using the Kona Surround Sound System</description>
    <arm_group_label>Renal Denervation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least 18 years of age&#xD;
&#xD;
          -  Average systolic blood pressure at least 160 mmHg&#xD;
&#xD;
          -  Refractory, stable hypertension despite being treated with at least three hypertensive&#xD;
             drugs&#xD;
&#xD;
          -  Two functioning kidneys, defined as eGFR &gt;= 45 ml/min&#xD;
&#xD;
          -  At least one renal artery on each side which is greater than 4 mm.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of nephrectomy or hydronephrosis&#xD;
&#xD;
          -  Renal stenosis &gt; 50%&#xD;
&#xD;
          -  Renal stent&#xD;
&#xD;
          -  Ambulatory blood pressure monitoring 24 hour average systolic blood pressure &lt;= 135&#xD;
             mmHg&#xD;
&#xD;
          -  Kidney stones which are symptomatic and/or &gt; 1 cm&#xD;
&#xD;
          -  History of abdominal surgery within the past 6 months&#xD;
&#xD;
          -  Heterogeneities in the kidneys (cysts or tumors)&#xD;
&#xD;
          -  Residual pyelonephritis&#xD;
&#xD;
          -  History of myocardial infarction, unstable angina pectoris, or cerebrovascular&#xD;
             accident within the last 6 months&#xD;
&#xD;
          -  Hemodynamically significant valvular heart disease&#xD;
&#xD;
          -  Implantable cardioverter defibrillator, pacemaker, neurostimulator or other device&#xD;
             incompatible with MRI&#xD;
&#xD;
          -  Body weight &gt; 150 kilograms&#xD;
&#xD;
          -  Target treatment depth &gt; 14 cm from the skin line&#xD;
&#xD;
          -  Pregnant, nursing or intends to become pregnant during the trial period&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St. Anne's University Hospital</name>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemocnice Na Homolee Hospital</name>
      <address>
        <city>Prague</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Angiography</name>
      <address>
        <city>Aukland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
    <country>New Zealand</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <study_first_submitted>August 19, 2013</study_first_submitted>
  <study_first_submitted_qc>August 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2013</study_first_posted>
  <last_update_submitted>October 27, 2015</last_update_submitted>
  <last_update_submitted_qc>October 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

